Observational study / 2002
Serum DHEA-S was positively correlated with bone mineral density in postmenopausal women, with vitamin D3 enhancing aromatase expression in human osteoblasts.
In 120 postmenopausal women (51-99 years old), researchers examined correlations between bone mineral density (BMD) and circulating hormones, while also testing osteoblast aromatase activity in cell culture. A significant positive correlation was identified between BMD and serum DHEA-S, whereas no correlation was seen with serum estradiol. In women younger than 69 years, strong positive correlations were seen between BMD and both serum DHEA-S and estrone. In cell experiments, 1,25-dihydroxyvitamin D3 enhanced and maintained glucocorticoid-induced aromatase gene expression in human osteoblasts.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional study and cell culture experiment
- Who was studied
- 120 postmenopausal women aged 51-99 years and primary cultured human osteoblasts
- What was measured
- Correlation between BMD and serum DHEA-S/estrogens; osteoblast aromatase activity
THE PAPER
Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts.
Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, Nawata H. Mech Ageing Dev, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.